55084-74-7

Usage

Uses

Used in Pharmaceutical Applications:
6-(Methylthio)-1H-pyrazolo[3,4]pyrimidine is used as an enzyme and receptor inhibitor for its potential therapeutic effects in treating various diseases. Its ability to inhibit specific biological targets makes it a promising candidate for drug development.
Used in Antimicrobial Applications:
Due to its potential antimicrobial properties, 6-(Methylthio)-1H-pyrazolo[3,4]pyrimidine can be used as an antimicrobial agent to combat bacterial and fungal infections. Its effectiveness in inhibiting the growth of microorganisms can contribute to the development of new antimicrobial drugs.
Used in Chemical Synthesis:
6-(Methylthio)-1H-pyrazolo[3,4]pyrimidine serves as a building block in the synthesis of other chemical compounds. Its unique structure and functional groups make it a valuable component in the creation of new molecules with various applications in different industries.
Used in Research and Development:
In the field of research and development, 6-(Methylthio)-1H-pyrazolo[3,4]pyrimidine is utilized for studying its chemical properties, potential applications, and interactions with biological systems. This knowledge can lead to the discovery of new uses and advancements in medicine and other industries.
Used in Medicinal Chemistry:
6-(Methylthio)-1H-pyrazolo[3,4]pyrimidine is employed in medicinal chemistry for the design and development of new drugs. Its unique structure and properties can be exploited to create novel compounds with improved pharmacological profiles and therapeutic potential.
Used in the Pharmaceutical Industry:
In the pharmaceutical industry, 6-(Methylthio)-1H-pyrazolo[3,4]pyrimidine is used as a key intermediate in the synthesis of various drug candidates. Its versatility and potential applications make it an important compound for the development of new medications to treat a wide range of diseases.

Upstream product

• 85426-79-5 4-chloro-6-methylmercapto-1H-pyrazolo[3,4-d]pyrimidine 
• 24521-76-4 6-thioxo-1,5,6,7-tetrahydropyrazolo<3,4-d>pyrimidin-4-one 
• 148256-82-0 4-chloro-2-(methylsulfanyl)pyrimidine-5-carboxaldehyde 
• 5334-26-9 6-(methylthio)pyrazolo<3,4-d>pyrimidin-4(5H)-one 

Downstream Products

• 1365170-00-8 C₁₄H₂₀N₄S 
• 1365170-20-2 C₁₂H₁₄N₄O₂S 
• 1365170-55-3 C₁₉H₂₄N₆O₂ 
• 1333535-64-0 C₂₅H₂₉N₇O₂S 
• 1333535-63-9 C₂₁H₂₉N₇O₂S 
• 1044144-04-8 C₂₁H₂₈N₆O₃S 
• 1044144-05-9 C₂₂H₃₀N₆O₂S 
• 1333535-62-8 C₂₂H₃₀N₆O₃S 
• 1333535-61-7 C₂₆H₃₇N₇O₃S 
• 1044143-59-0 C₁₉H₂₄N₆O₂S 
• 1044143-48-7 C₁₈H₂₂N₆ 
• 1044144-02-6 C₂₅H₃₅N₇O₃S 
• 927825-74-9 3-Iodo-6-methylsulfanyl-1H-pyrazolo[3,4-d]pyrimidine 

Relevant academic research and scientific papers

MODULATORS OF MITOTIC KINASES

The invention relates to compounds of Formula (I), a prodrug, a polymorph, a tautomer, an enantiomer, a stereoisomer, a solvate, an N-oxide, or a pharmaceutically acceptable salt thereof: (formula should be inserted here) which have inhibitory effect on one or more protein kinases that are involved in cell mitosis.

FUSED PYRAZOLE AS p38 MAP KINASE INHIBITORS

Fused pyrazoles effective as p38 MAP kinase inhibitors, methods of making the compounds, and methods of using the compounds for treatment of p38 MAP kinase-mediated diseases.

Heteroaryl-fused pyrazolo derivatives and methods for using the same

Compounds of the formula I: where A, B, X, Y, Z, k, R1, R2 and R3 are those defined herein, and compositions comprising the same. The present invention also provides methods for preparing compounds of formula I and using t